Merrimack Pharmaceuticals Stock Market Value
MACK Stock | USD 14.71 0.02 0.14% |
Symbol | Merrimack |
Merrimack Pharmaceuticals Price To Book Ratio
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Return On Assets (0.07) | Return On Equity (0.06) |
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Merrimack Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Merrimack Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Merrimack Pharmaceuticals.
03/26/2024 |
| 04/25/2024 |
If you would invest 0.00 in Merrimack Pharmaceuticals on March 26, 2024 and sell it all today you would earn a total of 0.00 from holding Merrimack Pharmaceuticals or generate 0.0% return on investment in Merrimack Pharmaceuticals over 30 days. Merrimack Pharmaceuticals is related to or competes with Amicus Therapeutics, Celldex Therapeutics, Puma Biotechnology, and Agios Pharm. Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company More
Merrimack Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Merrimack Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Merrimack Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 0.6897 | |||
Information Ratio | 0.0702 | |||
Maximum Drawdown | 9.42 | |||
Value At Risk | (1.20) | |||
Potential Upside | 1.38 |
Merrimack Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Merrimack Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Merrimack Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Merrimack Pharmaceuticals historical prices to predict the future Merrimack Pharmaceuticals' volatility.Risk Adjusted Performance | 0.0985 | |||
Jensen Alpha | 0.1539 | |||
Total Risk Alpha | 0.006 | |||
Sortino Ratio | 0.1211 | |||
Treynor Ratio | 0.9642 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Merrimack Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Merrimack Pharmaceuticals Backtested Returns
We consider Merrimack Pharmaceuticals not too volatile. Merrimack Pharmaceuticals has Sharpe Ratio of 0.15, which conveys that the firm had a 0.15% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Merrimack Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Merrimack Pharmaceuticals' Mean Deviation of 0.5855, risk adjusted performance of 0.0985, and Downside Deviation of 0.6897 to check out if the risk estimate we provide is consistent with the expected return of 0.18%. Merrimack Pharmaceuticals has a performance score of 11 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.18, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Merrimack Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Merrimack Pharmaceuticals is expected to be smaller as well. Merrimack Pharmaceuticals right now secures a risk of 1.21%. Please verify Merrimack Pharmaceuticals semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Merrimack Pharmaceuticals will be following its current price movements.
Auto-correlation | -0.16 |
Insignificant reverse predictability
Merrimack Pharmaceuticals has insignificant reverse predictability. Overlapping area represents the amount of predictability between Merrimack Pharmaceuticals time series from 26th of March 2024 to 10th of April 2024 and 10th of April 2024 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Merrimack Pharmaceuticals price movement. The serial correlation of -0.16 indicates that over 16.0% of current Merrimack Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.16 | |
Spearman Rank Test | 0.07 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Merrimack Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Merrimack Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Merrimack Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Merrimack Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Merrimack Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Merrimack Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Merrimack Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Merrimack Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Merrimack Pharmaceuticals stock over time.
Current vs Lagged Prices |
Timeline |
Merrimack Pharmaceuticals Lagged Returns
When evaluating Merrimack Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Merrimack Pharmaceuticals stock have on its future price. Merrimack Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Merrimack Pharmaceuticals autocorrelation shows the relationship between Merrimack Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Merrimack Pharmaceuticals.
Regressed Prices |
Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merrimack Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merrimack Pharmaceuticals' short interest history, or implied volatility extrapolated from Merrimack Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Merrimack Pharmaceuticals Correlation, Merrimack Pharmaceuticals Volatility and Merrimack Pharmaceuticals Alpha and Beta module to complement your research on Merrimack Pharmaceuticals. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Merrimack Stock analysis
When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Merrimack Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.